dalteparin has been researched along with Deficiency, Protein C in 14 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Priapism is a rare disorder defined as a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation." | 5.35 | Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency. ( Abu Sham'a, RA; Kufri, FH; Yassin, IH, 2008) |
" Coumarin-induced skin necrosis was a recurrent feature during oral anticoagulation therapy, forcing her physicians to treat her with nadroparin (Fraxiparin) for only a few months." | 3.72 | Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency. ( Alhenc-Gelas, M; Corazza, F; Demulder, A; Ferster, A; Loop, M, 2004) |
" The relationship between warfarin induced skin necrosis and level of anticoagulation was investigated." | 3.70 | Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin. ( Andrew, M; Halton, J; Jardine, L; Johnston, M; Marlar, R; Massicotte, MP; Monagle, P; Vegh, P; Webber, C, 1998) |
"Priapism is a rare disorder defined as a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation." | 1.35 | Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency. ( Abu Sham'a, RA; Kufri, FH; Yassin, IH, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 9 (64.29) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dogan, M | 1 |
Acikgoz, M | 1 |
Bora, A | 1 |
Başaranoğlu, M | 1 |
Oner, AF | 1 |
Loop, M | 1 |
Ferster, A | 1 |
Corazza, F | 1 |
Alhenc-Gelas, M | 1 |
Demulder, A | 1 |
Martinelli, P | 1 |
Maruotti, GM | 1 |
Coppola, A | 1 |
Agangi, A | 1 |
Paladini, D | 1 |
Grandone, E | 1 |
Di Minno, G | 1 |
Miljić, P | 1 |
Colović, MD | 1 |
Suvajdzić, N | 1 |
Hauck-Dlimi, B | 1 |
Zimmermann, R | 1 |
Eckstein, R | 1 |
Ringwald, J | 1 |
Shah, R | 1 |
Ferreira, P | 1 |
Karmali, S | 1 |
Le, D | 1 |
Abu Sham'a, RA | 1 |
Kufri, FH | 1 |
Yassin, IH | 1 |
Alhadad, A | 1 |
Acosta, S | 1 |
Sarabi, L | 1 |
Kölbel, T | 1 |
Imberti, D | 1 |
Pierfranceschi, MG | 1 |
Rosenzweig, N | 1 |
Strauss, T | 1 |
Rubinstein, M | 1 |
Paret, G | 1 |
Kenet, G | 1 |
May, C | 1 |
O'Rourke, K | 1 |
Jackson, K | 1 |
Francis, L | 1 |
Kennedy, GA | 1 |
Criado, PR | 1 |
Bernardelli, IM | 1 |
Rivitti, EA | 1 |
Sotto, MN | 1 |
Vilella, MA | 1 |
Valente, NY | 1 |
Martins, JE | 1 |
Monagle, P | 1 |
Andrew, M | 1 |
Halton, J | 1 |
Marlar, R | 1 |
Jardine, L | 1 |
Vegh, P | 1 |
Johnston, M | 1 |
Webber, C | 1 |
Massicotte, MP | 1 |
Ebina, Y | 1 |
Yamada, H | 1 |
Kato, EH | 1 |
Yamamoto, R | 1 |
Sakuragi, N | 1 |
Fujimoto, S | 1 |
14 other studies available for dalteparin and Deficiency, Protein C
Article | Year |
---|---|
Varicella-associated purpura fulminans and multiple deep vein thromboses: a case report.
Topics: Anticoagulants; Blood Coagulation Tests; Blood Component Transfusion; Chickenpox; Child; Glucocortic | 2009 |
Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency.
Topics: Age of Onset; Anticoagulants; Child; Coumarins; DNA Mutational Analysis; Ecchymosis; Family Health; | 2004 |
Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus.
Topics: Adult; Anticoagulants; Budd-Chiari Syndrome; Female; Humans; Labor, Induced; Nadroparin; Portasystem | 2006 |
Thrombosis of lienal vein and acute consumptive coagulopathy following warfarin administration in a patient with severe protein C deficiency.
Topics: Acute Disease; Anticoagulants; Child; Disseminated Intravascular Coagulation; Humans; Male; Nadropar | 2000 |
Two successful pregnancies in a carrier of heterozygous factor V LEIDEN mutation with aplasia of the inferior vena cava and a history of proximal deep venous thrombosis.
Topics: Anticoagulants; Enoxaparin; Factor V; Female; Heterozygote; Humans; Iliac Vein; Live Birth; Mutation | 2014 |
Severe Congenital Protein C Deficiency: Practical Aspects of Management.
Topics: Anticoagulants; Enoxaparin; Female; Humans; Infant, Newborn; Liver Transplantation; Protein C; Prote | 2016 |
Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency.
Topics: Adult; Anticoagulants; Enoxaparin; Humans; Male; Priapism; Protein C Deficiency; Pulmonary Embolism; | 2008 |
Pulmonary embolism associated with protein C deficiency and abuse of anabolic-androgen steroids.
Topics: Anticoagulants; Blood Coagulation Factors; Dalteparin; Doping in Sports; Enoxaparin; Hematoma, Subdu | 2010 |
Successful protein C concentrate administration during initiation of oral anticoagulation in adult patients with severe congenital protein C deficiency: report of two cases.
Topics: Adult; Anticoagulants; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; E | 2008 |
Activated protein C concentrate treatment for skin necrosis under warfarin treatment in severe genetic protein C deficiency combined with prothrombin mutation and factor V Leiden.
Topics: Anticoagulants; Blood Coagulation; Blood Component Transfusion; Child; Enoxaparin; Factor V; Humans; | 2009 |
Purpura fulminans in a patient with paroxysmal nocturnal haemoglobinuria.
Topics: Amoxicillin; Anticoagulants; Blood Coagulation Tests; Citalopram; Contraindications; Drug Therapy, C | 2013 |
Childhood-onset skin necrosis resulting from protein C deficiency.
Topics: Blood Component Transfusion; Child, Preschool; Enoxaparin; Fibrinolytic Agents; Follow-Up Studies; H | 2007 |
Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin.
Topics: Adult; Anticoagulants; Biomarkers; Bone Density; Child; Drug Eruptions; Enoxaparin; Female; Heparin; | 1998 |
Thromboprophylaxis with low molecular weight heparin in thrombophilia-complicated pregnancy.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Dalteparin; Female; Humans; Pregnancy; Pregnancy C | 2002 |